🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Takami Sato

Thomas Jefferson University

ORCID: 0000-0003-2221-0415

Also affiliated with Sidney Kimmel Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

UNC Libraries(2020)10.17615/a8zp-dq08
Top 100%
0DataRank
Top 100%0 citations

Andrew E. Aplin, Yiling Lu, Sébastien Jeay, Carol L. Shields, Michal Barzily-Rokni +49 more

Papers

Driven by 13 papers — median percentile 0. Top paper: “Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors”.

Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0339
N/A
0.587DataRank · unranked
49 citations

Roberta Zappasodi, Hong Wang, Girish S. Naik, Takami Sato, Todd M. Bauer +13 more

Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-1016
N/A
0.524DataRank · unranked
32 citations

Timothy J. Purwin, Anna Han, Vivian Chua, Prem Patel, Usman Baqai +7 more

Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP1 signaling in dormant disseminated uveal melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.05.583565
N/A
0.104DataRank · unranked
1 citations

Melisa Lopez Anton, Timothy J. Purwin, Lornella Seeneevassen, Vivian Chua, Francis Waltrich +10 more

Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.101033
N/A
0DataRank · unranked
28 citations

S. S. Panteleev, Nicholas William Mazzanti, Mizue Terai, Takami Sato, Yuri Sykulev +1 more

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

Cancers(2021)10.3390/cancers13225749
N/A
0DataRank · unranked
22 citations

Ayako Shimada, Inna Chervoneva, Liam Hulse, Meggie Danielson, Jeffrey Swensen +6 more

BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors

Oncogene(2020)10.1038/s41388-020-01554-y
N/A
0DataRank · unranked
48 citations

Timothy J. Purwin, Nelisa Bechtel, Connie Liao, Vivian Chua, Erin L. Seifert +6 more

IGF1R Inhibition Enhances the Therapeutic Effects of Gq/11 Inhibition in Metastatic Uveal Melanoma Progression

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0147
N/A
0DataRank · unranked
6 citations

Bao Lam, Mizue Terai, Takahito Sugase, Ryota Tanaka, Eduardo Farias +9 more

Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth

Cancers(2023)10.3390/cancers15133451
N/A
0DataRank · unranked
10 citations

Dzmitry Mukha, Vivian Chua, Timothy J. Purwin, Manoela Tiago, Bhavik Modasia +15 more

Data from Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma

(2023)10.1158/1078-0432.c.6529851
N/A
0DataRank · unranked
0 citations

Monica Acosta, Robert Saddawi‐Konefka, Ayush Kishore, Simone Lubrano, Frederico Gomes +13 more

Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress

Science Signaling(2024)10.1126/scisignal.adn8376
N/A
0DataRank · unranked
6 citations

Melisa Lopez-Anton, Mizue Terai, Ryota Tanaka, Usman Baqai, Timothy J. Purwin +13 more

Correction to: BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors

Oncogene(2021)10.1038/s41388-021-01645-4
N/A
0DataRank · unranked
2 citations

Timothy J. Purwin, Nelisa Bechtel, Connie Liao, Vivian Chua, Erin L. Seifert +6 more

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

UNC Libraries(2020)10.17615/a8zp-dq08
Top 100%
0DataRank
Top 100%0 citations

Andrew E. Aplin, Yiling Lu, Sébastien Jeay, Carol L. Shields, Michal Barzily-Rokni +49 more

Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ -Driven Uveal Melanoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3363
N/A
0DataRank · unranked
77 citations

Monica Acosta, Robert Saddawi‐Konefka, Ayush Kishore, Simone Lubrano, Frederico Gomes +13 more